Catalyst Wire Dossier Catalyst Wire Dossier

OPRX-106

TNFR-Fc fusion protein · Protalix Biotherapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPRX-106, covering 2015-08-05 to 2016-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis [Phase 2]

See pricing